Literature DB >> 8556302

CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1.

E Fransen1, V Lemmon, G Van Camp, L Vits, P Coucke, P J Willems.   

Abstract

L1 is a neuronal cell adhesion molecule with important functions in the development of the nervous system. The gene encoding L1 is located near the telomere of the long arm of the X chromosome in Xq28. We review here the evidence that several X-linked mental retardation syndromes including X-linked hydrocephalus (HSAS), MASA syndrome, X-linked complicated spastic paraparesis (SP1) and X-linked corpus callosum agenesis (ACC) are all due to mutations in the L1 gene. The inter- and intrafamilial variability in families with an L1 mutation is very wide, and patients with HSAS, MASA, SP1 and ACC can be present within the same family. Therefore, we propose here to refer to this clinical syndrome with the acronym CRASH, for Corpus callosum hypoplasia, Retardation, Adducted thumbs, Spastic paraplegia and Hydrocephalus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8556302     DOI: 10.1159/000472311

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  61 in total

Review 1.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 2.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 3.  Is the transportation highway the right road for hereditary spastic paraplegia?

Authors:  Andrew H Crosby; Christos Proukakis
Journal:  Am J Hum Genet       Date:  2002-09-24       Impact factor: 11.025

4.  L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.

Authors:  Thorsten Maretzky; Marc Schulte; Andreas Ludwig; Stefan Rose-John; Carl Blobel; Dieter Hartmann; Peter Altevogt; Paul Saftig; Karina Reiss
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth.

Authors:  John D Whittard; Takeshi Sakurai; Melanie R Cassella; Mihaela Gazdoiu; Dan P Felsenfeld
Journal:  Mol Biol Cell       Date:  2006-04-05       Impact factor: 4.138

6.  Identification of a duplication of Xq28 associated with bilateral periventricular nodular heterotopia.

Authors:  J M Fink; W B Dobyns; R Guerrini; B A Hirsch
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

7.  L1 cell adhesion molecule is not required for small-diameter primary afferent sprouting after deafferentation.

Authors:  S A Runyan; R R Roy; H Zhong; P E Phelps
Journal:  Neuroscience       Date:  2007-10-18       Impact factor: 3.590

8.  Lumbar Cerebrospinal Fluid Biomarkers of Posthemorrhagic Hydrocephalus of Prematurity: Amyloid Precursor Protein, Soluble Amyloid Precursor Protein α, and L1 Cell Adhesion Molecule.

Authors:  Diego M Morales; Shawgi A Silver; Clinton D Morgan; Deanna Mercer; Terri E Inder; David M Holtzman; Michael J Wallendorf; Rakesh Rao; James P McAllister; David D Limbrick
Journal:  Neurosurgery       Date:  2017-01-01       Impact factor: 4.654

Review 9.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

10.  A new activity of doublecortin in recognition of the phospho-FIGQY tyrosine in the cytoplasmic domain of neurofascin.

Authors:  Krishnakumar Kizhatil; Yi-Xin Wu; Anindita Sen; Vann Bennett
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.